Equities

Evolent Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Evolent Health Inc

Actions
Health CareHealth Care Providers
  • Price (USD)2.79
  • Today's Change0.150 / 5.68%
  • Shares traded2.87m
  • 1 Year change-72.02%
  • Beta0.2658
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

  • Revenue in USD (TTM)2.05bn
  • Net income in USD-180.89m
  • Incorporated2014
  • Employees4.50k
  • Location
    Evolent Health Inc1812 NORTH MOORE ST, SUITE 1705ARLINGTON 22209United StatesUSA
  • Phone+1 (571) 389-6000
  • Fax+1 (571) 389-6001
  • Websitehttps://www.evolent.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CapsoVision Inc13.09m-22.56m226.25m----11.06--17.29-0.4873-0.48730.28260.4368----------------53.13---172.37--4.50--0.00--20.54---76.01------
908 Devices Inc57.64m-57.10m234.89m246.00--1.72--4.08-1.61-0.11161.623.770.31231.764.17234,296.80-30.94-18.01-37.82-19.6749.3552.89-99.07-78.453.12--0.00--18.7227.11-98.37--8.96--
Simulations Plus Inc78.68m-64.25m247.60m212.00--1.95--3.15-3.20-3.203.906.310.4701--4.28371,113.20-38.39-2.50-40.84-2.6559.6069.96-81.66-7.29----0.00--13.0913.74-750.17--7.57-24.21
Applied Energetics Inc1.15m-13.02m256.97m21.00------222.85-0.0599-0.05990.0053-0.00330.3065--7.7054,908.57-345.27-139.08-454.84-208.3658.5860.61-1,126.59-473.16---------7.78---24.71--51.42--
Quanterix Corp130.20m-95.66m268.12m471.00--0.8519--2.06-2.33-2.333.216.740.30451.444.06276,439.50-22.37-13.18-25.81-14.5351.5356.14-73.47-45.092.31--0.0029--12.3019.36-35.89---20.86--
Shoulder Innovations Inc41.63m-34.45m269.06m61.00--1.82--6.46-1.91-1.912.247.18----------------76.67---82.75--9.80--0.0913--64.07---50.85------
Sight Sciences Inc76.05m-46.11m283.39m216.00--4.37--3.73-0.8955-0.89551.471.230.58541.426.71352,092.60-35.49-35.50-39.37-38.5386.8382.63-60.63-94.208.93-76.380.384---1.4727.897.27---10.54--
Carlsmed Inc-100.00bn-100.00bn291.19m100.00--2.73----------4.01------------------------11.91--0.1265--97.16---31.49------
Trubridge Inc349.88m5.42m292.68m3.20k52.571.629.130.83650.37090.370924.2312.020.8737257.086.17109,338.401.39-0.91071.60-1.0353.1650.131.59-1.141.902.400.4768--0.9464.5256.05--61.10--
Owlet Inc99.64m-42.45m301.46m80.00------3.03-2.75-2.756.08-2.341.523.804.361,245,500.00-60.37-64.44-244.32-331.1152.0644.29-39.68-58.720.9074-2.48----44.529.4054.08---17.23--
Senseonics Holdings Inc29.30m-63.77m306.85m117.00--3.92--10.47-1.65-1.650.75651.920.2483.625.22250,410.30-53.98-71.11-70.98-94.7541.11-14.81-217.65-594.095.93-29.180.3109--0.36621.08-30.18--16.46--
Evolent Health Inc2.05bn-180.89m311.37m4.50k--0.3697--0.1516-1.57-1.5717.857.550.829--5.17456,456.00-5.17-5.93-6.41-8.0018.4221.07-6.24-7.16--0.1890.5572--30.0930.0434.31---6.87--
Delcath Systems Inc79.60m1.20m328.77m96.001,070.122.86235.854.130.00870.00872.103.251.021.267.70829,197.901.54-94.541.90-143.9786.2981.311.50-339.8513.71--0.00--1,701.7088.1044.66--87.69--
Rxsight Inc142.09m-35.73m330.58m498.00--1.20--2.33-0.8782-0.87823.506.720.45911.405.74285,313.30-11.54-19.50-12.45-21.5074.9857.17-25.15-52.0011.44--0.0004--57.09128.6143.52--5.89--
Data as of Feb 13 2026. Currency figures normalised to Evolent Health Inc's reporting currency: US Dollar USD

Institutional shareholders

55.50%Per cent of shares held by top holders
HolderShares% Held
Cadian Capital Management LPas of 30 Sep 202511.73m9.99%
Morgan Stanley & Co. LLCas of 31 Dec 20259.04m7.70%
BlackRock Fund Advisorsas of 31 Dec 20258.21m6.99%
The Vanguard Group, Inc.as of 31 Dec 20257.98m6.80%
Fidelity Management & Research Co. LLCas of 30 Sep 20257.65m6.52%
UBS Securities LLCas of 31 Dec 20256.03m5.14%
Engaged Capital LLCas of 30 Sep 20255.66m4.82%
Jane Street Capital LLCas of 31 Dec 20252.95m2.52%
Rock Springs Capital Management LPas of 30 Sep 20252.95m2.51%
SSgA Funds Management, Inc.as of 31 Dec 20252.94m2.51%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.